Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

CyberKnife for inoperable renal tumors: Canadian pioneering experience.

Nair VJ, Szanto J, Vandervoort E, Cagiannos I, Breau R, Malone C, Avruch L, Pantarotto J, Malone S.

Can J Urol. 2013 Oct;20(5):6944-9. Review.

PMID:
24128835
2.

CyberKnife radiosurgery for stage I lung cancer: results at 36 months.

Brown WT, Wu X, Fayad F, Fowler JF, Amendola BE, García S, Han H, de la Zerda A, Bossart E, Huang Z, Schwade JG.

Clin Lung Cancer. 2007 Sep;8(8):488-92.

PMID:
17922973
3.

Radiofrequency ablation of renal tumors in the solitary kidney.

Krambeck AE, Farrell MA, Callstrom MR, Atwell TD, Charboneau JW, Chow GK, Dimarco DS, Patterson DE.

Can J Urol. 2008 Aug;15(4):4163-8; discussion 4168.

PMID:
18706143
4.

Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.

Svedman C, Karlsson K, Rutkowska E, Sandström P, Blomgren H, Lax I, Wersäll P.

Acta Oncol. 2008;47(8):1578-83. doi: 10.1080/02841860802123196.

PMID:
18607859
5.

Single fraction radiosurgery for the treatment of renal tumors.

Staehler M, Bader M, Schlenker B, Casuscelli J, Karl A, Roosen A, Stief CG, Bex A, Wowra B, Muacevic A.

J Urol. 2015 Mar;193(3):771-5. doi: 10.1016/j.juro.2014.08.044. Epub 2014 Aug 14.

PMID:
25132240
6.

Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship.

Siva S, Jackson P, Kron T, Bressel M, Lau E, Hofman M, Shaw M, Chander S, Pham D, Lawrentschuk N, Wong LM, Goad J, Foroudi F.

Radiother Oncol. 2016 Mar;118(3):540-6. doi: 10.1016/j.radonc.2016.01.027. Epub 2016 Feb 9.

PMID:
26873790
7.

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.

Siva S, Chesson B, Bressel M, Pryor D, Higgs B, Reynolds HM, Hardcastle N, Montgomery R, Vanneste B, Khoo V, Ruben J, Lau E, Hofman MS, De Abreu Lourenco R, Sridharan S, Brook NR, Martin J, Lawrentschuk N, Kron T, Foroudi F.

BMC Cancer. 2018 Oct 23;18(1):1030. doi: 10.1186/s12885-018-4916-2.

8.

Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors.

Brown WT, Wu X, Wen BC, Fowler JF, Fayad F, Amendola BE, García S, De La Zerda A, Huang Z, Schwade JG.

Comput Aided Surg. 2007 Sep;12(5):253-61.

PMID:
17957532
9.

Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.

Raman JD, Thomas J, Lucas SM, Bensalah K, Lotan Y, Trimmer C, Cadeddu JA.

Can J Urol. 2008 Apr;15(2):3980-5.

PMID:
18405445
10.

Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.

Hara W, Tran P, Li G, Su Z, Puataweepong P, Adler JR Jr, Soltys SG, Chang SD, Gibbs IC.

Neurosurgery. 2009 Feb;64(2 Suppl):A26-32. doi: 10.1227/01.NEU.0000339118.55334.EA.

PMID:
19165071
11.

Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.

Raman JD, Raj GV, Lucas SM, Williams SK, Lauer EM, Ahrar K, Matin SF, Leveillee RJ, Cadeddu JA.

BJU Int. 2010 Feb;105(4):496-500. doi: 10.1111/j.1464-410X.2009.08776.x. Epub 2009 Aug 13.

12.

CyberKnife frameless stereotactic radiosurgery for spinal lesions: clinical experience in 125 cases.

Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S, Welch WC.

Neurosurgery. 2004 Jul;55(1):89-98; discussion 98-9.

PMID:
15214977
13.

Preserved renal function after percutaneous radiofrequency ablation for renal tumors: experience of a single institution.

Ofude M, Kitagawa Y, Koda W, Ueno S, Kadono Y, Konaka H, Mizokami A, Gabata T, Namiki M.

Anticancer Res. 2013 Oct;33(10):4669-73.

PMID:
24123047
14.

A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.

Siva S, Pham D, Gill S, Corcoran NM, Foroudi F.

BJU Int. 2012 Dec;110(11 Pt B):E737-43. doi: 10.1111/j.1464-410X.2012.11550.x. Epub 2012 Oct 29. Review.

15.

Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.

Boda-Heggemann J, Dinter D, Weiss C, Frauenfeld A, Siebenlist K, Attenberger U, Ottstadt M, Schneider F, Hofheinz RD, Wenz F, Lohr F.

Radiat Oncol. 2012 Jun 18;7:92. doi: 10.1186/1748-717X-7-92.

16.

Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases.

Kano H, Iyer A, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD.

Neurosurgery. 2011 Dec;69(6):1232-9. doi: 10.1227/NEU.0b013e31822b2fdc.

PMID:
21716155
17.

Imaging-guided radiofrequency ablation of solid renal tumors.

Farrell MA, Charboneau WJ, DiMarco DS, Chow GK, Zincke H, Callstrom MR, Lewis BD, Lee RA, Reading CC.

AJR Am J Roentgenol. 2003 Jun;180(6):1509-13.

PMID:
12760910
18.

Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.

Memarsadeghi M, Schmook T, Remzi M, Weber M, Pötscher G, Lammer J, Kettenbach J.

Eur J Radiol. 2006 Aug;59(2):183-9. Epub 2006 May 24.

PMID:
16725292
19.

A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.

Svedman C, Sandström P, Pisa P, Blomgren H, Lax I, Kälkner KM, Nilsson S, Wersäll P.

Acta Oncol. 2006;45(7):870-5.

PMID:
16982552
20.

Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.

Ranck MC, Golden DW, Corbin KS, Hasselle MD, Liauw SL, Stadler WM, Hahn OM, Weichselbaum RR, Salama JK.

Am J Clin Oncol. 2013 Dec;36(6):589-95. doi: 10.1097/COC.0b013e31825d52b2.

PMID:
22868242

Supplemental Content

Support Center